5,7-Dichloro-N-(3-fluorophenyl)thiazolo[4,5-d]pyrimidine-2-sulfonamide

Catalog No. :
ACHTAA639
CAS No. :
1000576-41-9
Molecular Formula :
C11H5Cl2FN4O2S2
Molecular Weight :
379.23

IUPAC Name:5,7-dichloro-N-(3-fluorophenyl)thiazolo[4,5-d]pyrimidine-2-sulfonamide

5,7-Dichloro-N-(3-fluorophenyl)thiazolo[4,5-d]pyrimidine-2-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$439.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5,7-Dichloro-N-(3-fluorophenyl)thiazolo[4,5-d]pyrimidine-2-sulfonamide
IUPAC Name5,7-dichloro-N-(3-fluorophenyl)thiazolo[4,5-d]pyrimidine-2-sulfonamide
MDL No.MFCD09877987
Molecular FormulaC11H5Cl2FN4O2S2
Molecular Weight379.23
SMILESO=S(C1=NC2=NC(Cl)=NC(Cl)=C2S1)(NC3=CC=CC(F)=C3)=O
InChI KeyXJCPXOTZRUPZBJ-UHFFFAOYSA-N
Synonym5,7-DICHLORO-N-(3-FLUOROPHENYL)THIAZOLO[4,5-D]PYRIMIDINE-2-SULFONAMIDE;Thiazolo[4,5-d]pyrimidine-2-sulfonamide, 5,7-dichloro-N-(3-fluorophenyl)-
CAS No.1000576-41-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHTAA639 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBNJ219 route compound structure diagram
    ACFBNJ2191993-09-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHTAA639 route product structure diagram
    ACHTAA6391000576-41-9
Inquiry

2. ACHTAA639 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBNJ219 route compound structure diagram
    ACFBNJ2191993-09-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHTAA639 route product structure diagram
    ACHTAA6391000576-41-9
Inquiry

Comments (0)